Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211860 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects
A Phase 1 study, sponsored by Essentialis.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01211860 is a Phase 1 study that has completed, run by Essentialis. The registered enrollment target is 9 participants.
The verdict
NCT01211860, a Phase 1 study, has completed, sponsored by Essentialis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Once a day oral administration with DCCR is the optimal dosing regimen
Interventions
- DRUG Diazoxide Choline Controlled-Release Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-10 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01211860
The ClinicalTrials.gov registry entry for NCT01211860 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essentialis, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diazoxide Choline Controlled-Release Tablet is the first listed.
NCT01211860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01211860 about?
NCT01211860 is a clinical study titled "Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects". Once a day oral administration with DCCR is the optimal dosing regimen
What is the current status of trial NCT01211860?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2010-10. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01211860?
The interventions under investigation include: Diazoxide Choline Controlled-Release Tablet (DRUG).
Who is sponsoring clinical trial NCT01211860?
This trial is sponsored by Essentialis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.